HK1027026A1 - Swallow tablet comprising paracetamol - Google Patents

Swallow tablet comprising paracetamol

Info

Publication number
HK1027026A1
HK1027026A1 HK00105436A HK00105436A HK1027026A1 HK 1027026 A1 HK1027026 A1 HK 1027026A1 HK 00105436 A HK00105436 A HK 00105436A HK 00105436 A HK00105436 A HK 00105436A HK 1027026 A1 HK1027026 A1 HK 1027026A1
Authority
HK
Hong Kong
Prior art keywords
paracetamol
swallow tablet
swallow
tablet
Prior art date
Application number
HK00105436A
Other languages
English (en)
Inventor
Timothy James Grattan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1027026A1 publication Critical patent/HK1027026A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
HK00105436A 1997-03-05 2000-08-30 Swallow tablet comprising paracetamol HK1027026A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704524.9A GB9704524D0 (en) 1997-03-05 1997-03-05 Composition
PCT/EP1998/001284 WO1998038983A2 (fr) 1997-03-05 1998-02-27 Comprimes a avaler contenant du paracetamol

Publications (1)

Publication Number Publication Date
HK1027026A1 true HK1027026A1 (en) 2001-01-05

Family

ID=10808717

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105436A HK1027026A1 (en) 1997-03-05 2000-08-30 Swallow tablet comprising paracetamol

Country Status (36)

Country Link
US (1) US6316025B1 (fr)
EP (1) EP0981334B1 (fr)
JP (1) JP2001513801A (fr)
KR (1) KR100465895B1 (fr)
CN (1) CN100389751C (fr)
AP (1) AP1084A (fr)
AR (1) AR011919A1 (fr)
AT (1) ATE240720T1 (fr)
AU (1) AU721851B2 (fr)
BG (1) BG64348B1 (fr)
BR (1) BR9807992A (fr)
CA (1) CA2283408C (fr)
CO (1) CO4940406A1 (fr)
CY (1) CY2367B1 (fr)
CZ (1) CZ294078B6 (fr)
DE (1) DE69814850T2 (fr)
DK (1) DK0981334T3 (fr)
EA (1) EA001918B1 (fr)
ES (1) ES2199435T3 (fr)
GB (1) GB9704524D0 (fr)
HK (1) HK1027026A1 (fr)
HU (1) HU224983B1 (fr)
ID (1) ID22233A (fr)
IL (1) IL131552A (fr)
MY (1) MY119722A (fr)
NO (1) NO327456B1 (fr)
NZ (1) NZ337418A (fr)
PE (1) PE68899A1 (fr)
PL (1) PL190988B1 (fr)
PT (1) PT981334E (fr)
SK (1) SK282277B6 (fr)
TR (1) TR199902175T2 (fr)
TW (1) TW508242B (fr)
UA (1) UA59388C2 (fr)
WO (1) WO1998038983A2 (fr)
ZA (1) ZA981832B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
NZ508291A (en) * 1999-11-24 2002-09-27 Mcneil Ppc Inc Use of acetaminophen in a medicament for treating migraine symptoms
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
CA2521902A1 (fr) * 2003-04-11 2004-10-21 Pfizer Inc. Combinaison pharmaceutique a base d'eletriptan et de bicarbonate de sodium
US20050276847A1 (en) * 2004-05-28 2005-12-15 Roberts Michael S Oral delivery system
CA2566384C (fr) 2004-05-28 2010-08-03 Imaginot Pty Ltd. Systeme d'administration orale de compose therapeutique
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
CN101048155A (zh) * 2004-10-28 2007-10-03 诺瓦提斯公司 含有对乙酰氨基酚、咖啡因和任选的阿司匹林以及用于增强吸收的碱性剂的组合物
JP2008543851A (ja) * 2005-06-13 2008-12-04 ポール・ローゼンバーグ 催吐剤封入カプセル
US9060950B2 (en) * 2005-06-13 2015-06-23 Paul H. Rosenberg, Proximate Concepts, LLC. Emetic embedded capsule
KR100702069B1 (ko) * 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
US9757455B2 (en) 2005-11-28 2017-09-12 Johnson & Johnson Consumer Inc. Oral therapeutic compound delivery system
GB0607085D0 (en) * 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
WO2008008120A1 (fr) * 2006-07-14 2008-01-17 Fmc Corporation Forme solide
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
EP2203165B1 (fr) * 2007-08-07 2013-05-22 Stellenbosch University Paracetamol pour l'utilisation dans le traitement du glaucome
KR101687580B1 (ko) 2016-07-19 2016-12-20 주식회사 씨.월드 의자 등받이부와 프레임부 조립구조
JP7472116B2 (ja) 2018-11-19 2024-04-22 ジャズ ファーマシューティカルズ アイルランド リミテッド 耐アルコール性製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (fr) 1981-07-13 1985-02-05 Francis J. Sterbenz Compose d'apap et d'antiacide
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
ES2060736T3 (es) * 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (fr) * 1989-09-01 1991-03-02 Ronald Nash Duvall Compose medicinal effervescent a teneur reduite en sodium pour le soulagement des symptomes du rhume et des allergies
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel

Also Published As

Publication number Publication date
DE69814850T2 (de) 2004-03-11
BG64348B1 (bg) 2004-11-30
NO327456B1 (no) 2009-07-06
BG103714A (en) 2000-05-31
PL335502A1 (en) 2000-04-25
WO1998038983A2 (fr) 1998-09-11
EP0981334A1 (fr) 2000-03-01
AR011919A1 (es) 2000-09-13
KR20000075897A (ko) 2000-12-26
ID22233A (id) 1999-09-23
HU224983B1 (en) 2006-05-29
SK282277B6 (sk) 2002-01-07
AP9901638A0 (en) 1999-09-30
CN100389751C (zh) 2008-05-28
HUP0001501A2 (hu) 2000-09-28
DK0981334T3 (da) 2003-09-22
PL190988B1 (pl) 2006-02-28
TW508242B (en) 2002-11-01
EA199900709A1 (ru) 2000-08-28
AU6828298A (en) 1998-09-22
BR9807992A (pt) 2000-03-08
GB9704524D0 (en) 1997-04-23
AU721851B2 (en) 2000-07-13
CA2283408C (fr) 2007-01-02
CA2283408A1 (fr) 1998-09-11
HUP0001501A3 (en) 2001-01-29
CZ294078B6 (cs) 2004-09-15
TR199902175T2 (xx) 1999-12-21
PE68899A1 (es) 1999-09-26
MY119722A (en) 2005-07-29
AP1084A (en) 2002-07-23
JP2001513801A (ja) 2001-09-04
US6316025B1 (en) 2001-11-13
UA59388C2 (uk) 2003-09-15
EA001918B1 (ru) 2001-10-22
CN1253497A (zh) 2000-05-17
CZ314899A3 (cs) 2000-03-15
KR100465895B1 (ko) 2005-01-13
ZA981832B (en) 1998-12-11
IL131552A (en) 2004-08-31
PT981334E (pt) 2003-10-31
ES2199435T3 (es) 2004-02-16
CO4940406A1 (es) 2000-07-24
NO994294L (no) 1999-09-03
WO1998038983A3 (fr) 1998-12-17
EP0981334B1 (fr) 2003-05-21
ATE240720T1 (de) 2003-06-15
DE69814850D1 (de) 2003-06-26
SK119799A3 (en) 2000-02-14
CY2367B1 (en) 2004-06-04
NO994294D0 (no) 1999-09-03
NZ337418A (en) 2000-05-26
IL131552A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
PL340337A1 (en) Drugs
IL131552A0 (en) Swallow tablet comprising paracetamol
ZA987551B (en) Solid pharmaceutical dosage forms
GB9814501D0 (en) Medication dosage reminder device
GB9726563D0 (en) Novel pharmaceutical
GB9726566D0 (en) Novel pharmaceutical
EP1145714A4 (fr) Medicaments
EG23694A (en) Novel pharmaceutical
AU134671S (en) Pacifier
GB9826000D0 (en) Tablets
IL121696A (en) Pacifier
SI0981334T1 (en) Swallow tablet comprising paracetamol
GB9706376D0 (en) Novel pharmaceutical
CA80343S (en) Pharmaceutical tablet
CA83558S (en) Pharmaceutical tablet
CA84666S (en) Pharmaceutical tablet
CA80449S (en) Tablet
CA80217S (en) Tablet
CA80450S (en) Tablet
AU134179S (en) Tablet
AU134228S (en) Tablet
GB9717420D0 (en) Pill monitor
GB9725661D0 (en) Ptient-prompted medication
GB9605234D0 (en) Pharmaceutical tablet
GB9701143D0 (en) Pill administration device

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180226